Drug intelligence / Profile preview

beidougen

Development stage
Phase 4
Lead developer
The First Affiliated Hospital of Zhengzhou University
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

BeiDouGen is a Traditional Chinese Medicine (TCM) derived from the dried rhizome of *Menispermum dauricum* DC. It is characterized by a high concentration of isoquinoline alkaloids, most notably dauricine, daurisoline, and sinomenine. Historically utilized for its anti-inflammatory, analgesic, and anti-arrhythmic properties, BeiDouGen is currently being investigated in modern clinical trials for metabolic and reproductive indications. Specifically, it is being evaluated as an oral capsule or tablet, often in combination with the DPP-4 inhibitor sitagliptin, for the treatment of Type 2 Diabetes and Polycystic Ovary Syndrome (PCOS). In these contexts, it is hypothesized to improve insulin sensitivity, modulate glucose metabolism, and enhance ovarian function. Pharmacological studies suggest its effects are mediated through the antagonism of calcium channels and the inhibition of inflammatory signaling pathways such as NF-κB.

Brand names
BeiDouGen CapsuleBeidougen Tablet
Other names
Menispermum dauricumBDGMenispermi RhizomaNorth Mountain Bean Root
02

Targets

NF-κBCaV (Voltage-gated calcium channel protein complex)

Beyond the preview

Go deeper on beidougen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on beidougen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call